Latest Breaking News On - Global head of pharmaceuticals at bausch lomb - Page 1 : comparemela.com

NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘ Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Gary Phillips, MD, has been appointed as the new chairman of the Company’s supervisory board. Dr. Phillips succeeds Laurent Condomine, who will retire from the supervisory board after 11 years of leadership. Dr. Phillips will provide extensive guidance as the Company continues to advance its global development strategy with its planned second clinical registration pathway in head and neck cancer and its immunotherapy pathway as key focus areas. “I am truly honored and excited by my appointment as chairman of the Nanobiotix supervisory board,” said Dr. Phillips. “I look forward to working with the board and the entire organization toward delivering the breakthrough promise of its potentially transformational technology. Overcoming cancer a

New yorkUnited statesFrance generalWharton schoolUnited kingdomCity ofLaurent condomineMerck seronoGary phillipsAlpha omegaPhi beta kappaSchool of medicineMallinckrodt pharmaceuticalsReckitt benckiser pharmaceuticals north americaHead of global health healthcare industriesGiven the company